Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine
(2013) In BMC Cancer 13.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/079db51c-52f5-47ea-a32d-4d8d5237f249
- author
- Levin Tykjaer Jörgensen, Charlotte LU ; Ejlertsen, Bent ; Bjerre, Karsten D. ; Balslev, Eva ; Nielsen, Dorte Lisbet and Nielsen, Kirsten V
- publishing date
- 2013
- type
- Contribution to journal
- publication status
- published
- in
- BMC Cancer
- volume
- 13
- article number
- 541
- publisher
- BioMed Central (BMC)
- external identifiers
-
- scopus:84887274342
- ISSN
- 1471-2407
- DOI
- 10.1186/1471-2407-13-541
- language
- English
- LU publication?
- no
- id
- 079db51c-52f5-47ea-a32d-4d8d5237f249
- date added to LUP
- 2017-04-18 14:37:21
- date last changed
- 2022-03-16 21:43:03
@article{079db51c-52f5-47ea-a32d-4d8d5237f249,
author = {{Levin Tykjaer Jörgensen, Charlotte and Ejlertsen, Bent and Bjerre, Karsten D. and Balslev, Eva and Nielsen, Dorte Lisbet and Nielsen, Kirsten V}},
issn = {{1471-2407}},
language = {{eng}},
publisher = {{BioMed Central (BMC)}},
series = {{BMC Cancer}},
title = {{Gene aberrations of RRM1 and RRM2B and outcome of advanced breast cancer after treatment with docetaxel with or without gemcitabine}},
url = {{http://dx.doi.org/10.1186/1471-2407-13-541}},
doi = {{10.1186/1471-2407-13-541}},
volume = {{13}},
year = {{2013}},
}